Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).

Williams K, Brignell A, Randall M, Silove N, Hazell P

Open source

DOI
10.1002/14651858.cd004677.pub3
Published
2013 Aug 20
Container
The Cochrane database of systematic reviews
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/14651858.cd004677.pub3,
  title = {Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).},
  author = {Williams K and Brignell A and Randall M and Silove N and Hazell P},
  year = {2013},
  journal = {The Cochrane database of systematic reviews},
  doi = {10.1002/14651858.cd004677.pub3},
  url = {https://doi.org/10.1002/14651858.cd004677.pub3}
}

RIS

TY  - JOUR
TI  - Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
AU  - Williams K
AU  - Brignell A
AU  - Randall M
AU  - Silove N
AU  - Hazell P
PY  - 2013
JO  - The Cochrane database of systematic reviews
DO  - 10.1002/14651858.cd004677.pub3
UR  - https://doi.org/10.1002/14651858.cd004677.pub3
ER  - 

APA

K, W., A, B., M, R., N, S., & P, H. (2013). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd004677.pub3

Source records